Topics
- COVID-19 (101)
- Advertising (74)
- COVID-19 vaccines (62)
- Prescription medicines (29)
- Medical devices (20)
- Regulatory compliance (18)
- Alert/Advisory (14)
- Medicines safety (9)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Medicines (5)
- OTC medicines (3)
- Labelling and packaging (2)
- Shortages (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biologicals (1)
- Medicinal cannabis hub (1)
- Safety (1)
- Scheduling (1)
- Unapproved therapeutic goods (1)
Collection content
293 result(s) found, displaying 41 to 50
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 09-06-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesIndividual fined $10,664 for alleged unlawful importation of COVID-19 rapid antigen testsThe TGA has issued four infringement notices totalling $10,664 to an individual for alleged unlawful importation of COVID-19 rapid antigen tests (RATs).
- Media releasesIndividual fined $2,664 for alleged unlawful advertising in relation to COVID-19The TGA has issued one infringement notice totalling $2,664 to a Queensland based individual for alleged unlawful advertising of therapeutic goods in relation to COVID-19.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 26-05-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 19-05-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA removes age limit for BBIBP-CorV (Sinopharm) COVID-19 vaccine recognition for international travel to AustraliaThe TGA has determined that the BBIBP-CorV (Sinopharm) COVID-19 vaccine will be 'recognised' for all ages for the purpose of establishing a traveller's vaccination status when entering Australia.
- Media releasesTGA commences evaluation of Moderna COVID 19 vaccine (SPIKEVAX) for children aged 6 months to 5 years oldThe TGA has received and commenced evaluation of an application to extend the use of its COVID-19 vaccine, SPIKEVAX, to children aged 6 months to 5 years old.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 12-05-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- NewsCOVID-19 treatment: Gilead Sciences Pty Ltd, remdesivir (VEKLURY)On 10 July 2020 the Therapeutic Goods Administration (TGA) granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19
- NewsCOVID-19 treatment: GlaxoSmithKline Australia Pty Ltd, sotrovimab (XEVUDY)On 20 August 2021 the TGA granted provisional approval to GlaxoSmithKline Australia Pty Ltd in relation to sotrovimab (XEVUDY).